InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Browse the complete record of transactions filed by Young Jonathan, Chief Operating Officer. Insider active across 1 companies, notably Akero Therapeutics, Inc.. Cumulatively, 14 disclosures have been recorded. Total volume traded: €1.6m. The latest transaction was disclosed on 7 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations14 total
152,616 shares
Common Stock
SEC:0001193125-25-312092·
152,616 shares
Common Stock
SEC:0001193125-25-312092:0·
€15,10427,744 shares@ €0.54441.9% of flow
Common Stock
SEC:0001104659-22-003208·
€15,10427,744 shares@ €0.54440.9% of flow
Common Stock
SEC:0001104659-22-003208:0·
€393,62118,780 shares@ €20.959648.6% of flow
Common Stock
SEC:0001104659-21-135039·
€393,62118,780 shares@ €20.959624.3% of flow
Common Stock
SEC:0001104659-21-135039:0·
€253,78112,500 shares@ €20.302531.3% of flow
Common Stock
SEC:0001104659-21-112970·
€253,78112,500 shares@ €20.302515.7% of flow
Common Stock
SEC:0001104659-21-112970:0·
€4,6869,000 shares@ €0.52070.6% of flow
Common Stock
SEC:0001104659-21-093491·
€4,6869,000 shares@ €0.52070.3% of flow
Common Stock
SEC:0001104659-21-093491:0·
€65,6023,055 shares@ €21.47368.1% of flow
Common Stock
SEC:0001104659-21-075727·
€65,6023,055 shares@ €21.47364.0% of flow
Common Stock
SEC:0001104659-21-075727:0·
€77,4053,055 shares@ €25.33734.8% of flow
Common Stock
SEC:0001104659-21-060961:0·
€77,4053,055 shares@ €25.33739.6% of flow
Common Stock
SEC:0001104659-21-060961·
14 of 14 declarations
About Young Jonathan
Jonathan Young is the Chief Operating Officer of Akero Therapeutics, Inc. He is responsible for managing the company's operations, ensuring that processes are efficient and aligned with strategic objectives.
